The purpose of the following study was to analyze maternal and fetal outcomes in pregnant
patients with systemic lupus erythematosus (SLE) and the influence of SLE exacerbations …

Abstract Objective American Indian–Europeans, Asians, and African Americans have an
excess morbidity from systemic lupus erythematosus (SLE) and a higher prevalence of lupus …

Recent reports have associated NCF2, encoding a core component of the multi-protein
NADPH oxidase (NADPHO), with systemic lupus erythematosus (SLE) susceptibility in …

Introduction Infections are the leading cause of morbidity and mortality in patients with
systemic lupus erythematosus (SLE). Invasive fungal infections (IFI) comprise a group of …

Objective First, we describe the histopathological findings of renal biopsies (RBs) in patients
with RA and associated clinical manifestations. Second, we evaluated time evolution of RA …

DISCUSSION There is little evidence on the treatment with biological therapy in SA. First
publications of treatment with anti–TNF-α and its results are controversial. 4–6 Okuda and …

Diverse pleuropulmonary manifestations, including pleural effusion, rheumatoid nodulosis,
fibrosis, obliterans brochiolitis, bronchiectasias, vasculitis, drug-induced lung disease, and …

A white female patient developed overlapping features of systemic lupus erythematosus
(SLE) and systemic sclerosis (SSc) with severe pulmonary compromise. She was treated …

Twenty to 71% of patients with Sjögren's syndrome (SS) will develop systemic
manifestations. Objetive To characterize the clinical-serological presentation and the …

SIR, Pyoderma gangrenosum (PG) is an ulcerative skin disease of unknown origin and
about 25% of cases are associated with IBD, arthritis or lymphoproliferative disorder [1 4] …